Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Care Bare Rx vs Obu Health

Care Bare Rx
Graded #43

Higher grade

vs+15.100000000000001
Obu Health
Graded #332

Lower grade

The verdict

Care Bare Rx takes it — 75/100 to 59.9/100.

Care Bare Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Oral as well as injectable routes for both molecules plus a brand Ozempic lane, bundled with hair, TRT and sexual health.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCare Bare Rx +24
68
44
Dose & formulationCare Bare Rx +30
94
64
Clinical oversightObu Health +10
74
84
Labs & monitoringCare Bare Rx +9
62
53
FulfillmentCare Bare Rx +4
78
74
Contract termsCare Bare Rx +41
72
31
Care Bare Rx · left barObu Health · right bar

The numbers

MetricCare Bare RxObu Health
WeighScore75/10059.9/100
GradeCC
Scorecard rank#43#332
SemaglutideFrom $199/mo (shared weight-loss price)$190/mo (starting dose, plus a separate fee, compounded)
TirzepatideFrom $199/mo (shared weight-loss price)$239/mo (starting dose, plus a separate fee, compounded)
CoverageMulti-stateCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
Care Bare Rx

Graded #43 · C

Strengths

  • Oral tirzepatide as well as injectable — rare on this board
  • Brand Ozempic (from $705/mo) and oral Rybelsus beside the compounded line
  • LegitScript certified and HIPAA compliant
  • One platform if you also want hair, TRT, sexual health or NAD+

Where it loses points

  • The advertised "from $199/mo" is one figure shared across all weight-loss treatments — neither molecule priced separately
  • Per-dose pricing is quiz-gated, so a titrated cost cannot be modelled beforehand
  • No named clinicians, founding year or parent company disclosed
  • Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are
Obu Health

Graded #332 · C

Strengths

  • LegitScript-certified with publicly displayed ID (44206977)
  • Two named 503A compounding-pharmacy partners (Manifest Pharmacy SC + RX Compounding Store FL) — transparency above category baseline
  • Lower advertised semaglutide starting price ($190) than most multi-product peer platforms
  • Multi-product offering (GLP-1s + NAD+ + sermorelin + generic ED + birth control) for single-platform users
  • 24-hour US board-certified physician response window

Where it loses points

  • Per-dose pricing tiers not transparently published on product pages — only 'starting from' prices visible
  • No explicit state-coverage list disclosed; FAQ confirms restrictions exist 'based on state' without enumeration
  • Medical director not named publicly
  • No published consultation fee disclosure — unclear whether physician visit is included in medication price
  • All sales final per FAQ ('Federal and State law do not allow medication returns')

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard